General Info

Established in 1997, Echelon Biosciences Incorporated specializes in study and science of lipid cell signaling and critical metabolic enzymes, which provide new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections and cardiovascular disease. Based in Salt Lake City, Utah, the firm is owned by Frontier Scientific Inc., which specializes in Porphyrin and related compounds and Photo Dynamic Therapy. The company produces numerous products under categories, including assays, autotaxin, enzymes, inhibitors, lipids, lysophospholipid products and many more.